Azidothymidine Downregulates Insulin-Like Growth Factor-1 Induced Lipogenesis by Suppressing Mitochondrial Biogenesis and Mitophagy in Immortalized Human Sebocytes
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background Increased sebum secretion is considered the main causative factor in the pathogenesis of acne. There is an unmet pharmacological need for a novel drug that can control sebum production with a favorable adverse effect profile. Objective To investigate the effect of azidothymidine on lipid synthesis in sebocytes and to identify the underlying mechanism of the inhibitory effect of azidothymidine on insulinlike growth factor (IGF)-1-induced lipid synthesis in sebocytes. Methods Immortalized human sebocytes were used for the analysis. Thin-layer chromatography (TLC) and Oil Red O staining were performed to evaluate lipid synthesis in the sebocytes. The differentiation, lipid synthesis, mitochondrial biogenesis, and mitophagy in sebocytes were investigated. Results TLC and Oil Red O staining revealed that azidothymidine reduced IGF-1 induced lipid synthesis in the immortalized human sebocytes. Azidothymidine also reduced IGF-1-induced expression of transcriptional factors and enzymes involved in sebocyte differentiation and lipid synthesis, respectively. Moreover, we found that IGF-1 upregulated the levels of peroxisome proliferator-activated receptorgamma coactivator-1α, LC-3B, p62, and Parkin, major regulators of mitochondrial biogenesis and mitophagy in immortalized human sebocytes. In contrast, azidothymidine inhibited IGF-1 induced mitochondrial biogenesis and mitophagy in the sebocytes. Conclusion These results suggest that azidothymidine downregulates IGF-1-induced lipogenesis by dysregulating the quality of mitochondria through suppression of mitochondrial biogenesis and mitophagy in immortalized human sebocytes. Our study provides early evidence that azidothymidine may be an effective candidate for a new pharmacological agent for controlling lipogenesis in sebocytes.
Abstract
Background Increased sebum secretion is considered the main causative factor in the pathogenesis of acne. There is an unmet pharmacological need for a novel drug that can control sebum production with a favorable adverse effect profile. Objective To investigate the effect of azidothymidine on lipid synthesis in sebocytes and to identify the underlying mechanism of the inhibitory effect of azidothymidine on insulinlike growth factor (IGF)-1-induced lipid synthesis in sebocytes. Methods Immortalized human sebocytes were used for the analysis. Thin-layer chromatography (TLC) and Oil Red O staining were performed to evaluate lipid synthesis in the sebocytes. The differentiation, lipid synthesis, mitochondrial biogenesis, and mitophagy in sebocytes were investigated. Results TLC and Oil Red O staining revealed that azidothymidine reduced IGF-1 induced lipid synthesis in the immortalized human sebocytes. Azidothymidine also reduced IGF-1-induced expression of transcriptional factors and enzymes involved in sebocyte differentiation and lipid synthesis, respectively. Moreover, we found that IGF-1 upregulated the levels of peroxisome proliferator-activated receptorgamma coactivator-1α, LC-3B, p62, and Parkin, major regulators of mitochondrial biogenesis and mitophagy in immortalized human sebocytes. In contrast, azidothymidine inhibited IGF-1 induced mitochondrial biogenesis and mitophagy in the sebocytes. Conclusion These results suggest that azidothymidine downregulates IGF-1-induced lipogenesis by dysregulating the quality of mitochondria through suppression of mitochondrial biogenesis and mitophagy in immortalized human sebocytes. Our study provides early evidence that azidothymidine may be an effective candidate for a new pharmacological agent for controlling lipogenesis in sebocytes.
참고문헌 (17)
- Moradi Tuchayi S, "Acne vulgaris", Nat Rev Dis Primers, 1, pp.15029~ (2015)
- Im M, "Epigallocatechin-3-gallate suppresses IGF-I-induced lipogenesis and cytokine expression in SZ95 sebocytes", J Invest Dermatol, 132, pp.2700~2708 (2012)
- Zouboulis CC, "The truth behind this undeniable efficacy--recurrence rates and relapse risk factors of acne treatment with oral isotretinoin", Dermatology, 212, pp.99~100 (2006)
- Stankov MV, "Thymidine analogues suppress autophagy and adipogenesis in cultured adipocytes", Antimicrob Agents Chemother, 57, pp.543~551 (2013)
- Souza SJ, "Lipid profile of HIV-infected patients in relation to antiretroviral therapy: a review", Rev Assoc Med Bras (1992), 59, pp.186~198 (2013)
- Nolan D, "Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy", AIDS, 17, pp.1329~1338 (2003)
- Choi SR, "Tropomyosin-receptor kinase fused gene(TFG)regulates lipid production in human sebocytes", Sci Rep, 9, pp.6587~ (2019)
- Lyons A, "Insulin-like growth factor 1 signaling is essential for mitochondrial biogenesis and mitophagy in cancer cells", J Biol Chem, 292, pp.16983~16998 (2017)
- Palikaras K, "Coupling mitogenesis and mitophagy for longevity", Autophagy, 11, pp.1428~1430 (2015)
- Reyes A, "Human mitochondrial transcription factor A(mtTFA) : gene structure and characterization of related pseudogenes", Gene, 291, pp.223~232 (2002)
- Liu H, "From autophagy to mitophagy : the roles of P62 in neurodegenerative diseases", J Bioenerg Biomembr, 49, pp.413~422 (2017)
- Wang Y, "Mechanisms and roles of mitophagy in neurodegenerative diseases", CNS Neurosci Ther, 25, pp.859~875 (2019)
- Springer W, "Regulation of PINK1-Parkin-mediated mitophagy", Autophagy, 7, pp.266~278 (2011)
- Smith TM, "Insulin-like growth factor-1 induces lipid production in human SEB-1 sebocytes via sterol response element-binding protein-1", J Invest Dermatol, 126, pp.1226~1232 (2006)
- Caron M, "The HIV-1 nucleoside reverse transcriptase inhibitors stavudine and zidovudine alter adipocyte functions in vitro", AIDS, 18, pp.2127~2136 (2004)
- Lee JH, "The role of adipose tissue mitochondria : regulation of mitochondrial function for the treatment of metabolic diseases", Int J Mol Sci, 20, pp.4924~ (2019)
- Kajimoto K, "Essential role of citrate export from mitochondria at early differentiation stage of 3T3-L1 cells for their effective differentiation into fat cells, as revealed by studies using specific inhibitors of mitochondrial di- and tricarboxylate carriers", Mol Genet Metab, 85, pp.46~53 (2005)